Corona-Ruiz F, Rodríguez-Toledo A, Rodríguez-Ruiz JA

Language: Spanish
References: 20
Page: 110-115
PDF size: 230.77 Kb.

ABSTRACT

Chronic kidney disease (CKD) is a significant cause of morbidity in patients infected with the Acquired Immune Deficiency Virus (HIV). The prevalence of CKD in patients with HIV is estimated between 5-30%. There are factors that can influence the development of kidney damage such as low CD4 + lymphocytes or high blood virus values. This affects the decision of the initial treatment. Objective: Relate renal function in patients with HIV infection inexperienced antiretroviral (naïve) with levels of CD4 + lymphocytes. Materials and Methods: The present study is a prevalence study, which is a descriptive, retrospective cross-sectional design. General variables sex and age of patients. Analytical variables such as CD4 +, viral load, urea, and creatinine. Results: A 119 patients were included, 93.2% of male, the average age was 32 years, mean creatinine 0.87 mg/dL, mean Urea 24.4 mg/dL, eGFR CKD-EPI average 112 mL/ min/1.73m², CD4 + on average 363 mm³ cells and viral load average 334.671 copies/ml. Proteinuria in 16.6% of patients. The prevalence of 14.8% of the renal damage was found. The association of kidney damage with low CD4 + counts P = 0.0001. There is also an association with high viral load. P = 0.0001. Conclusions: The prevalence of renal damage was moderate. It is important always to a scrutiny of kidney damage in patients diagnosed with HIV.

REFERENCES

1. Górriz José L. et al: Documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH. Nefrología (Madrid) 2014jul.126 - 174

2. Lucas G.M., et al: Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectius Disease (Boston) 2014; 59(9): 96-138

3. Calza L, et al. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clin Exp Nephrol. 2014;18(1):104–12.

4. Crowley S, Rigsby M. Th e spectrum of HIV-associated renal disease. AIDS Clin Care. 1996;8(7):53–6.

5. Campbell LJ, et al: Spectrum of chronic kidney disease in HIVinfected patients. HIV Med 2009, 10(6):329-336.

6. Deti E, et al: Chronic Renal Failure in HIV-Infected Patients: Incidence and Risk Factors (ANRS CO3 Aquitaine Cohort, France). 17th Conference on Retroviruses and Opportunistics Infections San Francisco, CA.; 2010.

7. Winston J, et al: Kidney disease in patients with HIV infection and AIDS.Clin Infect Dis 2008 Dec 1;47(11):1449-57.

8. Phair J, Palella F: Renal disease in HIV-infected individuals. CurrOpin HIV AIDS. 2011 Jul;6(4):285-9..

9. Ibrahim F, et al: Immunodefi ciency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS 2010, 24(14):2239-2244.

10. Wyatt CM, et al: Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women. PLoS One. 2011;6(3):e18352.

11. Ekat E, Diafouka D. Renal dysfunction and factors associated among newly identifi ed HIV-infected patients in Brazzaville, Republic of Congo. J Int AIDS Soc. 2012;15 Suppl 4:18313.

12. Janakiraman H, et al: Correlation of CD4 Counts with Renal Disease in HIV Positive Patients. Saudi J Kidney Dis Transpl. 2008;19:603–7.

13. Krawczyk CS, et al: Factors associated with chronic renal failure in HIV infected ambulatory patients. AIDS 2004, 18(16):2171-2178.

14. Chioma PE, Arogundade F, Sanusi A, Kayode A, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23:741–6.

15. Odongo P et al: Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital, Northern Uganda. BMC Nephrol. 2015 Mar 31;16:43

16. Kaloustian KW, et al. Renal disease in an antiretroviral-naı¨ve HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant. 2007;22:2208–12

17. NORMA Ofi cial Mexicana NOM-001-SSA2-2010 Para la prevención y el control del virus de la inmunodefi ciencia humana. In: Secretaría de Salud, editor. México 2000.

18. NORMA Ofi cial Mexicana NOM-004-SSA3-2012 del expediente clínico. In: Secretaría de Salud, editor. México 2000.

19. Reglamento de la ley general de salud en materia de investigación en salud. In: Cámara de Diputados H. Congreso de la Unión, editor. Mexico2014.

20. Montañés BR, et al: Valoración de la nueva ecuación CKD-EPI para la estimación del fi ltrado glomerular. Nefrología (Madrid) 2010; 30(2): 185-194.